WebAug 21, 2024 · Arteriovenous (AV) hemodialysis access creation is recommended by international guidelines as the preferred method of hemodialysis access. However, most … WebApr 18, 2024 · The LEVANT II trial, a highly powered 54-site randomised controlled trial of 476 patients with symptomatic intermittent claudication or ischaemic pain while at rest and angiographically significant atherosclerosis, showed greater primary patency rates for those who had undergone angioplasty with a PCB as opposed to PTA (65.2% vs. 52.6%, p=0.02), …
Brachiocephalic Venoplasty and Stenting in patients
WebNov 29, 2024 · Treatment of cephalic arch stenosis (CAS) with standard plain old balloon angioplasty (POBA) in dysfunctional arteriovenous fistulas (AVF), is associated with early re-stenosis and higher failure rates compared to other lesions. Paclitaxel-coated balloons (PCB) may improve patency rates. This is a retrospective cohort study. Patients who … WebMar 20, 2024 · Background The main barriers to arterio-venous fistula (AVF) utilization are primary failure, long maturation duration, and low secondary patency rates. Methods In this retrospective cohort study, primary, secondary, functional primary, and functional secondary patency rates were calculated and compared between two age groups (< 75 years and > = … headaches at back of head throbbing
Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous …
WebCOMPARE Randomized Controlled Trial: 12-Month Results presented by Sabine Steiner, MD. LINC 2024. 12-Month Primary Endpoints: Binary Primary Patency = 83.0% for Ranger DCB and 81.5% for IN.PACT DCB (P non-inferiority <0.01). Freedom from Major Adverse Events = 91.0% for Ranger DCB and 92.6% for IN.PACT DCB (P non-inferiority <0.01).. Ranger II SFA … Web2-Year Trial Results. In this 2-Year Trial, Eluvia DES demonstrated the highest primary patency ever reported in an SFA US Pivotal Trial for DES or DCB 1. Highest-two year primary patency based on 24-month Kaplan-Meier estimates reported for IMPERIAL, IN.PACT SFA, ILLUMENATE, LEVANT II and Primary Randomisation for Zilver PTX RCT. WebPrimary patency: the interval from the time of access creationuntil first access thrombosis or any intervention to maintain or restore blood flow (NAVAC and SVS definition)4,15 Functional primary patency: the time from the first successful 2-needle cannulation until first intervention or access failure (NAVAC and SVS definition)4,15 headaches at base of back of skull